Clinical Trial Update: Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides

View source ↗

Summary

This completed clinical trial investigates how OCTN2 variants influence carnitine status and plasma triglycerides in patients with Carnitine transporter deficie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carnitine Transporter Deficiency

Snippet

Sponsor: University of California, San Francisco | Conditions: Carnitine Transporter Deficiency | Status: COMPLETED